Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10

Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10

US Patent 8961957 · Granted Feb 24, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions, methods and therapies for administering antigen peptide2021
Compositions, methods and therapies for administering antigen peptide2019
Therapy and methods for introducing immature and dendritic cells and/or cytotoxi2019
Therapy and methods of introducing immature dendritic cells and/or cytotoxic T l2018
Compositions, methods and therapies for administering antigen peptide2018
Dendritic cell tumor injection (DCTI) therapy2015
Antigen peptide and use thereof2014
Human lymphocyte vaccine adjuvant2012
Adoptive immune cells for tumor vaccines2011
Dendritic cell tumor injection (DCTI) therapy2011
Human lymphocyte medium adjuvant2010
Adoptive immune cells for tumor vaccines2010